DE3886363T3
(de)
*
|
1987-11-18 |
2004-09-09 |
Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville |
NANBV-Diagnostika
|
US5683864A
(en)
*
|
1987-11-18 |
1997-11-04 |
Chiron Corporation |
Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
|
US5712088A
(en)
*
|
1987-11-18 |
1998-01-27 |
Chiron Corporation |
Methods for detecting Hepatitis C virus using polynucleotides specific for same
|
US6171782B1
(en)
|
1987-11-18 |
2001-01-09 |
Chiron Corporation |
Antibody compositions to HCV and uses thereof
|
US5698390A
(en)
|
1987-11-18 |
1997-12-16 |
Chiron Corporation |
Hepatitis C immunoassays
|
US5714596A
(en)
*
|
1987-11-18 |
1998-02-03 |
Chiron Corporation |
NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
|
US5350671A
(en)
*
|
1987-11-18 |
1994-09-27 |
Chiron Corporation |
HCV immunoassays employing C domain antigens
|
US6861212B1
(en)
|
1987-11-18 |
2005-03-01 |
Chiron Corporation |
NANBV diagnostics and vaccines
|
AU650038B2
(en)
*
|
1988-03-11 |
1994-06-09 |
Abbott Laboratories |
CKS method of protein synthesis
|
JP2696116B2
(ja)
*
|
1988-09-30 |
1998-01-14 |
財団法人阪大微生物病研究会 |
非a非b肝炎患者の血清と抗原抗体反応するペプチド、及び該ペプチドをコードするdna
|
US5191064A
(en)
*
|
1988-09-30 |
1993-03-02 |
The Research Foundation For Microbial Diseases (Osaka University) |
Non-a, non-b hepatitis virus antigen peptide
|
JPH02167081A
(ja)
*
|
1988-12-21 |
1990-06-27 |
Tetsuo Nakamura |
非A非B型肝炎ウイルスゲノムRNA、cDNAおよびウイルス抗原蛋白質
|
WO1990011089A1
(en)
*
|
1989-03-17 |
1990-10-04 |
Chiron Corporation |
Nanbv diagnostics and vaccines
|
US6027729A
(en)
*
|
1989-04-20 |
2000-02-22 |
Chiron Corporation |
NANBV Diagnostics and vaccines
|
DE69033891T2
(de)
*
|
1989-05-18 |
2002-08-29 |
Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville |
NANBV-Diagnostika: Polynukleotide, geeignet für Reihenuntersuchungen auf Hepatitis C-Virus
|
JPH0330676A
(ja)
*
|
1989-06-28 |
1991-02-08 |
Sanwa Kagaku Kenkyusho Co Ltd |
非a非b型肝炎ウイルスのdna、そのクローン及びこれらの調製法
|
EP0416725A3
(en)
*
|
1989-07-14 |
1991-03-20 |
Chugai Seiyaku Kabushiki Kaisha |
Blood-borne non-a, non-b hepatitis specific protein, dna encoding it, and process for its production
|
ES2110411T3
(es)
*
|
1989-08-25 |
1998-02-16 |
Chiron Corp |
Metodos para cultivar el virus de la hepatitis c (hcv) en lineas celulares de linfocitos b o t.
|
US5372928A
(en)
*
|
1989-09-15 |
1994-12-13 |
Chiron Corporation |
Hepatitis C virus isolates
|
CA2065287C
(en)
*
|
1989-09-15 |
1999-12-21 |
Tatsuo Miyamura |
New hcv isolates
|
FR2654113A1
(fr)
*
|
1989-11-09 |
1991-05-10 |
Pasteur Institut |
Procede de diagnostic de virus appartenant a la famille des flaviviridae.
|
US7166287B1
(en)
|
1989-12-18 |
2007-01-23 |
Glaxo Wellcome Inc. |
Viral agent
|
LU87861A1
(fr)
|
1989-12-18 |
1991-10-08 |
Wellcome Found |
Agent viral
|
CA2032907C
(en)
*
|
1989-12-22 |
2002-05-14 |
Richard R. Lesniewski |
Hepatitis c assay
|
US5308750A
(en)
*
|
1989-12-22 |
1994-05-03 |
Abbott Laboratories |
Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same
|
EP0435229A1
(en)
*
|
1989-12-27 |
1991-07-03 |
Sanwa Kagaku Kenkyusho Co., Ltd. |
DNA of non-A, non-B hepatitis virus gene, its clone and use thereof
|
CA2036022A1
(en)
*
|
1990-02-09 |
1991-08-10 |
Tetsuo Nakamura |
Non-a, non-b hepatitis related nucleic acids, antigens, antibodies and their detection reagents
|
US5582968A
(en)
*
|
1990-02-16 |
1996-12-10 |
United Biomedical, Inc. |
Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis
|
US5106726A
(en)
*
|
1990-02-16 |
1992-04-21 |
United Biomedical, Inc. |
Synthetic peptides specific for the detection of antibodies to HCV
|
KR940000755B1
(ko)
*
|
1990-02-16 |
1994-01-29 |
유나이티드 바이오메디칼 인코오포레이티드 |
Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
|
US5639594A
(en)
*
|
1990-02-16 |
1997-06-17 |
United Biomedical, Inc. |
Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis
|
US5747239A
(en)
*
|
1990-02-16 |
1998-05-05 |
United Biomedical, Inc. |
Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines
|
EP0445801A3
(en)
*
|
1990-03-08 |
1992-07-01 |
Kuraray Co., Ltd. |
Peptide and its use
|
EP0447984A1
(en)
*
|
1990-03-20 |
1991-09-25 |
Abbott Laboratories |
Hyperimmune globulin against hepatitis C virus and method for making same
|
WO1991014779A1
(en)
*
|
1990-03-28 |
1991-10-03 |
Mitsui Toatsu Chemicals, Incorporated |
Diagnostic for hepatitis virus
|
JPH0436185A
(ja)
*
|
1990-03-28 |
1992-02-06 |
Kyowa Hakko Kogyo Co Ltd |
融合抗原ポリペプチド
|
KR100206150B1
(ko)
*
|
1990-04-04 |
1999-07-01 |
로버트 피. 블랙버언 |
항-에이치씨브이 항체에 대한 면역분석용 씨형 간염 바이러스(에이치디브이)항원의 조합체
|
US5712087A
(en)
*
|
1990-04-04 |
1998-01-27 |
Chiron Corporation |
Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
|
US6194140B1
(en)
|
1990-04-04 |
2001-02-27 |
Chiron Corporation |
HCV NS3 protein fragments having helicase activity and improved solubility
|
EP0527788B1
(en)
*
|
1990-04-04 |
2004-06-30 |
Chiron Corporation |
Hepatitis c virus protease
|
ES2152922T3
(es)
*
|
1990-04-06 |
2001-02-16 |
Genelabs Tech Inc |
Epitopos del virus de la hepatitis c.
|
JP3050395B2
(ja)
*
|
1990-06-12 |
2000-06-12 |
国立感染症研究所長 |
C型肝炎ウイルス抗原ポリペプチド、その産生方法および抗体の検出方法
|
CA2044296A1
(en)
*
|
1990-06-12 |
1991-12-13 |
Hiroaki Okamoto |
Oligonucleotide primers, and their application for high-fidelity detection of non-a, non-b hepatitis virus
|
AU652941B2
(en)
*
|
1990-06-25 |
1994-09-15 |
Research Foundation For Microbial Diseases Of Osaka University, The |
Non-A, Non-B hepatitis virus particles
|
EP0933426A1
(en)
*
|
1990-06-25 |
1999-08-04 |
The Research Foundation for Microbial Diseases of Osaka University |
Non-a, non-b hepatitis virus genomic cdna fragments and antigen polypeptides
|
US5747339A
(en)
*
|
1990-06-25 |
1998-05-05 |
Research Foundation For Microbial Diseases Of Osaka |
Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
|
ES2069298T3
(es)
*
|
1990-06-30 |
1995-05-01 |
Akzo Nobel Nv |
Secuencias no-a no-b.
|
EP0468657A3
(en)
*
|
1990-07-09 |
1992-02-05 |
Tonen Corporation |
Non-a non b hepatitis-specific antigen and its use in hepatitus diagnosis
|
ATE150086T1
(de)
*
|
1990-07-11 |
1997-03-15 |
Shionogi & Co |
Cdns-sequenz und detektion des hepatitis c-virus
|
WO1992001714A1
(en)
*
|
1990-07-24 |
1992-02-06 |
Yamanouchi Pharmaceutical Co., Ltd. |
Non-a non-b hepatitis virus antigen
|
CA2047792C
(en)
*
|
1990-07-26 |
2002-07-02 |
Chang Y. Wang |
Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
|
CA2049679C
(en)
*
|
1990-08-24 |
2005-06-21 |
Sushil G. Devare |
Hepatitis c assay utilizing recombinant antigens
|
US6172189B1
(en)
*
|
1990-08-24 |
2001-01-09 |
Abbott Laboratories |
Hepatitis C assay utilizing recombinant antigens
|
CA2090335A1
(en)
*
|
1990-08-25 |
1992-02-26 |
Suzanne Zebedee |
Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines
|
US7863008B2
(en)
|
1990-08-25 |
2011-01-04 |
Bioprocess Pty Ltd. |
Method for detecting NANBV associated seroconversion
|
EP0552297A1
(en)
*
|
1990-10-12 |
1993-07-28 |
Abbott Laboratories |
Hepatitis c virus antibody
|
JP3549201B2
(ja)
*
|
1990-10-24 |
2004-08-04 |
中外製薬株式会社 |
非a非b型肝炎特異的遺伝子の検出方法及び検出用試薬組成物
|
DE59109221D1
(de)
*
|
1990-11-03 |
2001-11-15 |
Dade Behring Marburg Gmbh |
HCV-spezifische Peptide, Mittel dazu und ihre Verwendung
|
DE4034982C2
(de)
*
|
1990-11-03 |
1999-12-23 |
Dade Behring Marburg Gmbh |
Synthetische Polypeptide zur Bestimmung von HCV-Antikörpern und HCV-Antigenen, Mittel dazu und ihre Verwendung in diesen Nachweis-Verfahren
|
DE4121431A1
(de)
*
|
1991-06-28 |
1993-01-07 |
Behringwerke Ag |
Synthetische core-peptide zur bestimmung von hcv-antikoerpern und hcv-antigenen, mittel dazu und ihre verwendung in diesen nachweis-verfahren
|
DE4112743C2
(de)
*
|
1991-04-19 |
2000-01-13 |
Dade Behring Marburg Gmbh |
Synthetische Core-Peptide zur Bestimmung von HCV-Antikörpern und HCV-Antigenen, Mittel dazu und ihre Verwendung in diesen Nachweis-Verfahren
|
DE4120281C2
(de)
*
|
1991-06-19 |
1999-11-25 |
Dade Behring Marburg Gmbh |
Immunchemisches Verfahren zum gleichzeitigen Nachweis von mehreren verschiedenen Antikörperspezifitäten, Peptidmischungen und Test dazu
|
US5753430A
(en)
*
|
1990-11-07 |
1998-05-19 |
Abbott Laboratories |
Monoclonal antibodies to hepatitis C virus and method for using same
|
DK0556320T3
(da)
*
|
1990-11-07 |
1999-10-18 |
Abbott Lab |
Monoklonale antistoffer mod Hepatitis C-virus og fremgangsmåde til anvendelse heraf
|
EP0485209A1
(en)
*
|
1990-11-08 |
1992-05-13 |
Immuno Japan Inc. |
Non A, non B hepatitis virus related antigen, antibody detection systems, polynucleotides and polypeptides
|
US6274148B1
(en)
|
1990-11-08 |
2001-08-14 |
Chiron Corporation |
Hepatitis C virus asialoglycoproteins
|
CZ289006B6
(cs)
*
|
1990-11-08 |
2001-10-17 |
Chiron Corporation |
Asialoglykoprotein hepatitis C viru, farmaceutická kompozice s jeho obsahem a jeho pouľití
|
WO1992009634A1
(en)
*
|
1990-11-29 |
1992-06-11 |
Toray Industries, Incorporated |
Non-a non-b hepatitis virus antigen protein
|
DK0488812T3
(da)
*
|
1990-11-30 |
1999-12-13 |
Japan Immuno Inc |
Non-A, non-B hepatitis-relaterede nucleinsyrer, antigener og antistoffer samt reagenser til deres påvisning
|
DE69029092T2
(de)
*
|
1990-12-14 |
1997-04-17 |
Innogenetics N.V., Gent |
Synthetische Antigene zum Nachweis von Antikörpern gegen Hepatitis C-Virus
|
US5910404A
(en)
|
1990-12-14 |
1999-06-08 |
Innogenetics N.V. |
Synthetic antigens for the detection of antibodies to hepatitis C virus
|
US6007982A
(en)
*
|
1990-12-14 |
1999-12-28 |
Innogenetics N.V. |
Synthetic antigens for the detection of antibodies to hepatitis C virus
|
KR930703613A
(ko)
*
|
1991-01-25 |
1993-11-30 |
챨스 엠. 브록 |
시료 희석물중 과산화물 디스뮤타제의 용도
|
KR930703361A
(ko)
*
|
1991-01-31 |
1993-11-29 |
찰스 엠. 브룩 |
추정의 c형 간염 바이러스(hcv) 외막 영역에 대한 모노클로날 항체 및 이의 사용 방법
|
AU640569B2
(en)
*
|
1991-03-26 |
1993-08-26 |
Dade International Inc. |
Assay for non-a non-b hepatitis
|
US5574132A
(en)
*
|
1991-04-05 |
1996-11-12 |
Biochem Immunosystems Inc. |
Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
|
CA2065690A1
(en)
*
|
1991-04-10 |
1992-10-11 |
Hiroaki Okamoto |
Non-a, non-b hepatitis related antigens, detection systems, polynucleotides and polypeptides
|
WO1992018532A1
(en)
*
|
1991-04-17 |
1992-10-29 |
Eisai Co., Ltd. |
Rna, dna and virus antigen protein of non-a non-b hepatitis virus
|
EP0510952A1
(en)
*
|
1991-04-26 |
1992-10-28 |
Immuno Japan Inc. |
Oligonucleotide primers and their application for high-fidelity detection of non-a, non-b hepatitis virus
|
JPH06508026A
(ja)
*
|
1991-05-08 |
1994-09-14 |
カイロン コーポレイション |
診断と治療に用いるhcvゲノム配列
|
ES2040615B1
(es)
*
|
1991-05-27 |
1994-05-16 |
Nebrda Fernando Javi Bartolome |
Procedimiento para el aislamiento y clonaje de cdnas derivados del virus c de la hepatitis.
|
FR2677372B1
(fr)
|
1991-06-06 |
1994-11-10 |
Pasteur Institut |
Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques.
|
BR9206131A
(pt)
*
|
1991-06-10 |
1995-05-02 |
Lucky Ltd |
Hepatite C: diagnóstico e vacinas
|
CA2070952A1
(en)
*
|
1991-06-11 |
1992-12-12 |
Makoto Seki |
Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same
|
RU2148587C1
(ru)
*
|
1991-06-24 |
2000-05-10 |
Чирон Корпорейшн |
Полипептид и способ его получения, реагент для иммуноанализа, способ определения присутствия антител и способ индукции иммунного ответа
|
DE4209215A1
(de)
|
1991-07-04 |
1993-01-07 |
Boehringer Mannheim Gmbh |
Hcv peptidantigene und verfahren zur bestimmung von hcv
|
AU2501392A
(en)
*
|
1991-08-21 |
1993-03-16 |
Abbott Laboratories |
Monoclonal antibodies to putative hcv ns5 proteins and methos for using same
|
AU2513592A
(en)
*
|
1991-08-21 |
1993-03-16 |
Abbott Laboratories |
Hepatitis c assay utilizing recombinant antigens to ns1
|
CA2115925A1
(en)
*
|
1991-08-21 |
1993-03-04 |
Suresh M. Desai |
Hepatitis c assay utilizing recombinant antigens from ns5 region
|
ATE161291T1
(de)
*
|
1991-08-27 |
1998-01-15 |
Hoffmann La Roche |
Verfahren und reagenzien zum nachweis von hepatitis c
|
PL171489B1
(pl)
*
|
1991-09-13 |
1997-05-30 |
Chiron Corp |
Sposób wytwarzania kompozycji immunogenicznej reagujacej immunologicznie krzyzowo z wieloma izolatami HCV PL
|
ZA927837B
(en)
*
|
1991-10-15 |
1994-03-11 |
Akzo Nv |
Monoclonal antibodiesto hepatitis C virus
|
JPH05130874A
(ja)
*
|
1991-11-07 |
1993-05-28 |
Sanwa Kagaku Kenkyusho Co Ltd |
ヒトC型肝炎ウイルスのcDNA、そのクローン及びこれらの利用法
|
AU3063992A
(en)
*
|
1991-11-07 |
1993-06-07 |
Dade International Inc. |
Epitope mapping ot the c33c region of hcv
|
EP0610436B9
(en)
|
1991-11-21 |
2003-03-26 |
Common Services Agency |
Hepatitis-c virus testing
|
JP3439209B2
(ja)
*
|
1992-01-31 |
2003-08-25 |
アボツト・ラボラトリーズ |
Hcv蛋白のための哺乳動物発現システム
|
US6709828B1
(en)
|
1992-03-06 |
2004-03-23 |
N.V. Innogenetics S.A. |
Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
|
US6667387B1
(en)
|
1996-09-30 |
2003-12-23 |
N.V. Innogenetics S.A. |
HCV core peptides
|
MA22842A1
(fr)
*
|
1992-03-27 |
1993-10-01 |
Smithkline Beecham Biolog |
Procede de preparation de compositions de vaccin.
|
US6620414B2
(en)
|
1992-03-27 |
2003-09-16 |
Smithkline Beecham Biologicals (S.A.) |
Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
|
US5866139A
(en)
*
|
1992-06-04 |
1999-02-02 |
Institut Pasteur |
Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications
|
US5980899A
(en)
*
|
1992-06-10 |
1999-11-09 |
The United States Of America As Represented By The Department Of Health And Human Services |
Identification of peptides that stimulate hepatitis C virus specific cytotoxic T cells
|
UA39944C2
(uk)
|
1992-07-07 |
2001-07-16 |
Чірон Корпорейшн |
Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
|
US5859230A
(en)
*
|
1992-07-30 |
1999-01-12 |
Genelabs Technologies, Inc. |
Non-A/non-B/non-C/non-D/non-E hepatitis agents and molecular cloning thereof
|
DE4240980A1
(de)
*
|
1992-08-07 |
1994-02-10 |
Boehringer Mannheim Gmbh |
HCV Peptidantigene und Verfahren zur Bestimmung von HCV
|
CA2143678A1
(en)
|
1992-09-10 |
1994-03-17 |
Kevin P. Anderson |
Compositions and methods for treatment of hepatitis c virus-associated diseases
|
US6995146B2
(en)
|
1992-09-10 |
2006-02-07 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of hepatitis C virus-associated diseases
|
US6391542B1
(en)
|
1992-09-10 |
2002-05-21 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of Hepatitis C virus-associated diseases
|
US6433159B1
(en)
|
1992-09-10 |
2002-08-13 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of Hepatitis C virus associated diseases
|
US6174868B1
(en)
|
1992-09-10 |
2001-01-16 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of hepatitis C virus-associated diseases
|
US6057093A
(en)
*
|
1992-09-28 |
2000-05-02 |
Chiron Corporation |
Methods and compositions for controlling translation of HCV proteins
|
CN1059928C
(zh)
*
|
1992-09-29 |
2000-12-27 |
天津普生生物科技有限公司 |
利用大肠杆菌制备可用来检验c型肝炎之抗原蛋白的方法
|
US6153378A
(en)
*
|
1992-10-16 |
2000-11-28 |
Bionova Corporation |
Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
|
EP0593291A3
(en)
*
|
1992-10-16 |
1995-03-15 |
Evernew Biotech Inc |
Non-structural protein of the hepatitis C virus, as well as diagnostic procedure and test kit.
|
JPH06153959A
(ja)
*
|
1992-10-16 |
1994-06-03 |
Evernew Biotec Inc |
C型肝炎ウィルスの非構造タンパク質及びそれを用いての診断方法及びキット
|
JP2778886B2
(ja)
*
|
1992-10-16 |
1998-07-23 |
エバーニュー バイオテック インコーポレイティド |
C型肝炎ウィルスのコア抗原タンパク質及びそれを用いての診断方法及びキット
|
WO1994013700A1
(en)
*
|
1992-12-07 |
1994-06-23 |
Akzo Nobel N.V. |
Peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv
|
EP0672065A1
(en)
*
|
1992-12-07 |
1995-09-20 |
Akzo Nobel N.V. |
Hepatitis c virus (hcv) non-structural-3 peptides, antibodies thereto and methods for the detection of hcv
|
AU6769594A
(en)
*
|
1993-04-22 |
1994-11-08 |
Genelabs Technologies, Inc. |
Hepatitis c virus immunodiagnostic antigens and antibodies
|
EP0984068B1
(en)
*
|
1993-04-27 |
2012-03-28 |
Innogenetics N.V. |
Sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
|
DE69434116T2
(de)
*
|
1993-05-05 |
2005-10-27 |
Common Services Agency |
Hepatitis-c virus typ 4,5 und 6
|
PL175360B1
(pl)
|
1993-05-10 |
1998-12-31 |
Chiron Corp |
Cząsteczka kwasu nukleinowego i kompozycja do wykrywania infekcji wirusa zapalenia wątroby typu C
|
ATE249838T1
(de)
|
1993-05-12 |
2003-10-15 |
Chiron Corp |
Konserviertes motiv der hepatitis c virus e2/ns1 region
|
AU8003894A
(en)
*
|
1993-10-29 |
1995-05-22 |
Srl Inc. |
Antigen peptide compound and immunoassay method
|
US5610009A
(en)
*
|
1994-01-28 |
1997-03-11 |
Abbott Laboratories |
Mammalian expression systems for hepatitis C virus envelope genes
|
US6156495A
(en)
*
|
1994-02-14 |
2000-12-05 |
Abbott Laboratories |
Hepatitis GB virus recombinant proteins and uses thereof
|
US5843450A
(en)
*
|
1994-02-14 |
1998-12-01 |
Abbott Laboratories |
Hepatitis GB Virus synthetic peptides and uses thereof
|
US6720166B2
(en)
|
1994-02-14 |
2004-04-13 |
Abbott Laboratories |
Non-a, non-b, non-c, non-c, non-d, non-e hepatitis reagents and methods for their use
|
US6051374A
(en)
*
|
1994-02-14 |
2000-04-18 |
Abbott Laboratories |
Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
|
US5981172A
(en)
*
|
1994-02-14 |
1999-11-09 |
Abbott Laboratories |
Non-A, non-B, non-C, non-D, non-E Hepatitis reagents and methods for their use
|
US6451578B1
(en)
|
1994-02-14 |
2002-09-17 |
Abbott Laboratories |
Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
|
US6558898B1
(en)
|
1994-02-14 |
2003-05-06 |
Abbott Laboratories |
Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
|
US5824507A
(en)
*
|
1994-05-20 |
1998-10-20 |
Genelabs Technologies, Inc. |
Hepatitis G virus and molecular cloning thereof
|
US5874563A
(en)
*
|
1994-05-20 |
1999-02-23 |
Genelabs Technologies, Inc. |
Hepatitis G virus and molecular cloning thereof
|
JP3217600B2
(ja)
|
1994-07-12 |
2001-10-09 |
株式会社先端生命科学研究所 |
非a非b型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
|
PT1510580E
(pt)
|
1994-07-29 |
2009-02-18 |
Novartis Vaccines & Diagnostic |
Polipéptido e2 truncado da hepatite c e métodos para a sua obtenção
|
PT773957E
(pt)
*
|
1994-07-29 |
2005-11-30 |
Chiron Corp |
Polipeptidos truncados e1 e e2 de hepatite c inovadores, e metodos de obtencao dos mesmos
|
DE4428705A1
(de)
|
1994-08-12 |
1996-02-15 |
Boehringer Mannheim Gmbh |
Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
|
US5955318A
(en)
*
|
1995-08-14 |
1999-09-21 |
Abbott Laboratories |
Reagents and methods useful for controlling the translation of hepatitis GBV proteins
|
US5807670A
(en)
*
|
1995-08-14 |
1998-09-15 |
Abbott Laboratories |
Detection of hepatitis GB virus genotypes
|
US5709997A
(en)
*
|
1995-08-14 |
1998-01-20 |
Abbott Laboratories |
Nucleic acid detection of hepatitis GB virus
|
US6127116A
(en)
*
|
1995-08-29 |
2000-10-03 |
Washington University |
Functional DNA clone for hepatitis C virus (HCV) and uses thereof
|
GB9517926D0
(en)
|
1995-09-01 |
1995-11-01 |
Biocine Spa |
Binding protein
|
US5851758A
(en)
*
|
1995-10-25 |
1998-12-22 |
Childrens Research Institute |
Cytopathic replication of hepatitis C virus in a new cell line
|
US5837442A
(en)
|
1995-11-29 |
1998-11-17 |
Roche Molecular Systems, Inc. |
Oligonucleotide primers for amplifying HCV nucleic acid
|
US5851759A
(en)
*
|
1996-04-19 |
1998-12-22 |
Chiron Corporation |
Heteroduplex tracking assay (HTA) for genotyping HCV
|
JP3715027B2
(ja)
|
1996-05-07 |
2005-11-09 |
シスメックス株式会社 |
C型肝炎ウイルス感染症診断薬
|
CU22642A1
(es)
*
|
1996-12-12 |
2000-12-22 |
Ct Ingenieria Genetica Biotech |
Secuencia de adnc derivadas del genoma del virus de la hepatitis c y su uso
|
US7338759B1
(en)
|
1997-03-04 |
2008-03-04 |
Washington University |
HCV variants
|
US7049428B1
(en)
|
1998-03-04 |
2006-05-23 |
Washington University |
HCV variants
|
ES2328536T3
(es)
|
1997-05-06 |
2009-11-13 |
Novartis Vaccines And Diagnostics, Inc. |
Produccion intracelular de polipeptido e2 truncado de la hepatitis c.
|
US6010848A
(en)
*
|
1997-07-02 |
2000-01-04 |
Smithkline Beecham Corporation |
Screening methods using an atpase protein from hepatitis C virus
|
US6153392A
(en)
*
|
1997-07-30 |
2000-11-28 |
Bionova Corporation |
Devices and methods comprising an HBcAg from hepatitis B virus
|
WO1999018198A1
(en)
|
1997-10-06 |
1999-04-15 |
Chiron S.P.A. |
Hepatitis c receptor protein cd81
|
CA2308606A1
(en)
|
1997-11-06 |
1999-05-20 |
Chiron S.P.A. |
Neisserial antigens
|
EP1037974B1
(en)
|
1997-12-11 |
2007-10-03 |
SmithKline Beecham Corporation |
Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds
|
EP2278011A3
(en)
|
1998-01-14 |
2012-03-07 |
Novartis Vaccines and Diagnostics S.r.l. |
Neisseria meningitidis antigens
|
GB9808932D0
(en)
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
AU761780B2
(en)
|
1998-05-01 |
2003-06-12 |
Glaxosmithkline Biologicals Sa |
Neisseria meningitidis antigens and compositions
|
EP2286792A1
(en)
|
1999-02-26 |
2011-02-23 |
Novartis Vaccines and Diagnostics, Inc. |
Microemulsions with an adsorbent surface, comprising a microdroplet emulsion
|
WO2000050078A1
(en)
|
1999-02-26 |
2000-08-31 |
Chiron Corporation |
Use of bioadhesives and adjuvants for the mucosal delivery of antigens
|
EP1228217B1
(en)
|
1999-04-30 |
2012-11-21 |
Novartis Vaccines and Diagnostics S.r.l. |
Conserved neisserial antigens
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
CA2377525A1
(en)
*
|
1999-07-19 |
2001-03-29 |
Epimmune, Inc. |
Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions
|
AU784203B2
(en)
|
1999-10-29 |
2006-02-23 |
Glaxosmithkline Biologicals S.A. |
Neisserial antigenic peptides
|
US7196066B1
(en)
|
1999-11-03 |
2007-03-27 |
Powderject Vaccines, Inc. |
DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
|
PT1233782E
(pt)
*
|
1999-12-01 |
2009-02-13 |
Novartis Vaccines & Diagnostic |
Estimulação da produção de anticorpos específicos para o hcv
|
EP2275129A3
(en)
|
2000-01-17 |
2013-11-06 |
Novartis Vaccines and Diagnostics S.r.l. |
Outer membrane vesicle (OMV) vaccine comprising N. meningitidis serogroup B outer membrane proteins
|
CA2405521C
(en)
|
2000-04-05 |
2010-06-29 |
Schering Corporation |
Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties
|
CN1432022A
(zh)
|
2000-04-19 |
2003-07-23 |
先灵公司 |
含有烷基和芳基丙氨酸p2部分的丙型肝炎病毒的大环ns3-丝氨酸蛋白酶抑制剂
|
US6630298B2
(en)
|
2000-06-15 |
2003-10-07 |
Chiron Corporation |
HCV antigen/antibody combination assay
|
EP1829891B1
(en)
*
|
2000-06-15 |
2012-12-26 |
Novartis Vaccines and Diagnostics, Inc. |
Immunoassays for Anti-HCV Antibodies
|
AR029851A1
(es)
|
2000-07-21 |
2003-07-16 |
Dendreon Corp |
Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c
|
CN1446201A
(zh)
|
2000-07-21 |
2003-10-01 |
先灵公司 |
用作丙型肝炎病毒ns3-丝氨酸蛋白酶抑制剂的新型肽
|
IL153670A0
(en)
|
2000-07-21 |
2003-07-06 |
Schering Corp |
Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
|
US7244721B2
(en)
|
2000-07-21 |
2007-07-17 |
Schering Corporation |
Peptides as NS3-serine protease inhibitors of hepatitis C virus
|
KR100801123B1
(ko)
|
2000-08-17 |
2008-02-05 |
트리펩 아베 |
리바비린 함유 백신 및 이것의 사용 방법
|
US7022830B2
(en)
|
2000-08-17 |
2006-04-04 |
Tripep Ab |
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
|
US6858590B2
(en)
|
2000-08-17 |
2005-02-22 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
US6680059B2
(en)
|
2000-08-29 |
2004-01-20 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
MX357775B
(es)
|
2000-10-27 |
2018-07-20 |
J Craig Venter Inst Inc |
Acidos nucleicos y proteinas de los grupos a y b de estreptococos.
|
KR20030091946A
(ko)
|
2000-12-12 |
2003-12-03 |
쉐링 코포레이션 |
C형 간염 바이러스의 ns3-세린 프로테아제억제제로서의 디아릴 펩티드
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
EP1399183B1
(en)
|
2001-05-31 |
2010-06-30 |
Novartis Vaccines and Diagnostics, Inc. |
Chimeric alphavirus replicon particles
|
US7196183B2
(en)
|
2001-08-31 |
2007-03-27 |
Innogenetics N.V. |
Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
|
AR045702A1
(es)
|
2001-10-03 |
2005-11-09 |
Chiron Corp |
Composiciones de adyuvantes.
|
ATE406912T1
(de)
|
2001-12-12 |
2008-09-15 |
Novartis Vaccines & Diagnostic |
Immunisierung gegen chlamydia tracheomatis
|
NZ533861A
(en)
|
2002-01-23 |
2006-03-31 |
Schering Corp |
Proline compounds as NS3-serine protease inhibitors for use in treatment of hepatitis C virus infection
|
US7501134B2
(en)
|
2002-02-20 |
2009-03-10 |
Novartis Vaccines And Diagnostics, Inc. |
Microparticles with adsorbed polypeptide-containing molecules
|
AU2003218111B8
(en)
|
2002-03-11 |
2008-11-20 |
Lab 21 Limited |
Methods and compositions for identifying and characterizing hepatitis C
|
US7598421B2
(en)
|
2002-05-08 |
2009-10-06 |
Ucl Biomedica Plc |
Materials for the delivery of biologically-active material to cells
|
WO2003100020A2
(en)
|
2002-05-24 |
2003-12-04 |
Restoragen, Inc. |
Methods and constructs for high yield expression of clostripain
|
ES2312806T3
(es)
|
2002-09-09 |
2009-03-01 |
Novartis Vaccines And Diagnostics, Inc. |
Ensayo de vhc.
|
EP2977470B1
(en)
|
2002-10-16 |
2018-01-03 |
Gen-Probe Incorporated |
Compositions and methods for detecting west nile virus
|
US7927840B2
(en)
|
2006-09-11 |
2011-04-19 |
Gen Probe Incorporated |
Method for detecting West Nile Virus nucleic acids in the 3′ non-coding region
|
EP1585542B1
(en)
|
2002-12-27 |
2012-06-13 |
Novartis Vaccines and Diagnostics, Inc. |
Immunogenic compositions containing phospholipid
|
US7695725B2
(en)
|
2003-02-06 |
2010-04-13 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
ES2382332T3
(es)
|
2003-02-06 |
2012-06-07 |
Aduro Biotech |
Listeria atenuada para entrar en células no fagocíticas, vacunas que comprenden esta listeria y métodos de uso de las mismas
|
AU2004224425B2
(en)
|
2003-02-06 |
2010-06-24 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
US7731967B2
(en)
|
2003-04-30 |
2010-06-08 |
Novartis Vaccines And Diagnostics, Inc. |
Compositions for inducing immune responses
|
WO2005021584A2
(en)
|
2003-08-26 |
2005-03-10 |
Schering Corporation |
Novel peptidomimetic ns3-serine protease inhibitors of hepatitis c virus
|
ES2596753T3
(es)
|
2003-08-29 |
2017-01-11 |
Fujirebio Europe N.V. |
Nuevo clado del virus de la hepatitis C y secuencias prototipo del mismo
|
EP2062590A1
(en)
|
2003-09-22 |
2009-05-27 |
Green Peptide Co., Ltd. |
Peptide derived from Hepatitis C virus
|
CA2540031A1
(en)
|
2003-09-26 |
2005-04-07 |
Schering Corporation |
Macrocyclic inhibitors of hepatitis c virus ns3 serine protease
|
CA2540858C
(en)
*
|
2003-10-14 |
2009-12-08 |
Intermune, Inc. |
Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication
|
JP2007532479A
(ja)
|
2003-11-20 |
2007-11-15 |
シェーリング コーポレイション |
C型肝炎ウイルスns3プロテアーゼの脱ペプチド化インヒビター
|
US7842289B2
(en)
|
2003-12-24 |
2010-11-30 |
Aduro Biotech |
Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
|
JP2007525511A
(ja)
|
2004-02-27 |
2007-09-06 |
シェーリング コーポレイション |
C型肝炎ウイルスns3セリンプロテアーゼの新規のインヒビターとしての化合物
|
US7205330B2
(en)
|
2004-02-27 |
2007-04-17 |
Schering Corporation |
Inhibitors of hepatitis C virus NS3 protease
|
KR20060127162A
(ko)
|
2004-02-27 |
2006-12-11 |
쉐링 코포레이션 |
C형 간염 바이러스 ns3 세린 프로테아제의 억제제로서의화합물
|
JP2007525512A
(ja)
|
2004-02-27 |
2007-09-06 |
シェーリング コーポレイション |
C型肝炎ウイルスns3セリンプロテアーゼのインヒビターとしての3,4−(シクロペンチル)−縮合プロリン化合物
|
CN1984922A
(zh)
|
2004-05-20 |
2007-06-20 |
先灵公司 |
用作丙型肝炎病毒ns3丝氨酸蛋白酶抑制剂的取代脯氨酸
|
US20060165716A1
(en)
|
2004-07-29 |
2006-07-27 |
Telford John L |
Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
|
JP2008511633A
(ja)
|
2004-08-27 |
2008-04-17 |
シェーリング コーポレイション |
C型肝炎ウィルスns3セリンプロテアーゼの阻害因子としてのアシルスルホンアミド化合物
|
EP1802778B1
(en)
|
2004-08-27 |
2011-10-05 |
Novartis Vaccines and Diagnostics, Inc. |
Hcv multiple epitope fusion antigens with modified proteolytic cleavage sites and uses thereof
|
CA2927595C
(en)
|
2004-12-22 |
2023-01-31 |
Ambrx, Inc. |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
WO2006116423A2
(en)
|
2005-04-26 |
2006-11-02 |
Eisai Co., Ltd |
Compositions and methods for cancer immunotherapy
|
US7968697B2
(en)
|
2005-05-25 |
2011-06-28 |
Chrontech Pharma Ab |
Hepatitis C virus non-structural NS3/4A fusion gene
|
EP1919478B1
(en)
|
2005-06-02 |
2016-03-23 |
Merck Sharp & Dohme Corp. |
Combination of hcv protease inhibitors with a surfactant
|
EP1891089B1
(en)
|
2005-06-02 |
2014-11-05 |
Merck Sharp & Dohme Corp. |
HCV protease inhibitors in combination with food
|
ES2886923T3
(es)
|
2005-09-20 |
2021-12-21 |
Menarini Silicon Biosystems Spa |
Métodos y composición para generar sondas de ADN de secuencia única, marcaje de sondas de ADN y el uso de estas sondas
|
WO2007135707A1
(ja)
|
2006-05-18 |
2007-11-29 |
Nichia Corporation |
樹脂成形体及び表面実装型発光装置並びにそれらの製造方法
|
DK2054431T3
(da)
|
2006-06-09 |
2012-01-02 |
Novartis Ag |
Konformere af bakterielle adhæsiner
|
US8071561B2
(en)
|
2007-08-16 |
2011-12-06 |
Chrontech Pharma Ab |
Immunogen platform
|
US20090214593A1
(en)
|
2007-08-16 |
2009-08-27 |
Tripep Ab |
Immunogen platform
|
NZ585556A
(en)
|
2007-11-07 |
2012-07-27 |
Celldex Therapeutics Inc |
Antibodies that bind human dendritic and epithelial cell 205 (dec-205)
|
US8815253B2
(en)
|
2007-12-07 |
2014-08-26 |
Novartis Ag |
Compositions for inducing immune responses
|
CN103694337B
(zh)
|
2008-02-08 |
2016-03-02 |
Ambrx公司 |
经修饰瘦素多肽和其用途
|
WO2009143085A1
(en)
|
2008-05-19 |
2009-11-26 |
Anza Therapeutics, Inc. |
Compositions comprising prfa*mutant listeria and methods of use thereof
|
CA2737026C
(en)
|
2008-09-26 |
2019-12-24 |
Ambrx, Inc. |
Modified animal erythropoietin polypeptides and their uses
|
TW201032801A
(en)
|
2008-12-12 |
2010-09-16 |
Schering Corp |
Deuterated compounds as hepatitis C virus (HCV) inhibitors
|
CN102427828A
(zh)
|
2009-03-09 |
2012-04-25 |
威廉·亨利 |
含具有信号肽的细菌毒素作为载体的半抗原-载体缀合物和它们在免疫原性组合物中的用途
|
WO2010138791A1
(en)
|
2009-05-29 |
2010-12-02 |
Schering Corporation |
Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
|
US20110300205A1
(en)
|
2009-07-06 |
2011-12-08 |
Novartis Ag |
Self replicating rna molecules and uses thereof
|
US20120276047A1
(en)
|
2009-11-25 |
2012-11-01 |
Rosenblum Stuart B |
Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
|
EP2333074A1
(en)
|
2009-12-14 |
2011-06-15 |
Robert Steinfeld |
Substances and methods for the treatment of lysosmal storage diseases
|
EP2516430B1
(en)
|
2009-12-22 |
2014-11-05 |
Merck Sharp & Dohme Corp. |
Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases
|
ES2644804T3
(es)
|
2010-01-27 |
2017-11-30 |
Ab Pharma Ltd |
Compuestos poliheterocíclicos como inhibidores de HCV
|
AU2011224698A1
(en)
|
2010-03-09 |
2012-11-01 |
Merck Sharp & Dohme Corp. |
Fused Tricyclic Silyl Compounds and methods of use thereof for the treatment of viral diseases
|
CN103154034B
(zh)
|
2010-04-13 |
2016-06-08 |
塞尔德克斯医疗公司 |
结合人cd27的抗体及其用途
|
BR112013000391B8
(pt)
|
2010-07-06 |
2022-10-04 |
Novartis Ag |
Composição de emulsão catiônica de óleo em água e seu uso
|
CA2805440A1
(en)
|
2010-07-26 |
2012-02-09 |
Merck Sharp & Dohme Corp. |
Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
|
EP2621279B1
(en)
|
2010-09-29 |
2018-04-04 |
Merck Sharp & Dohme Corp. |
Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
|
US9156872B2
(en)
|
2011-04-13 |
2015-10-13 |
Merck Sharp & Dohme Corp. |
2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
SG194485A1
(en)
|
2011-04-13 |
2013-12-30 |
Merck Sharp & Dohme |
2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
WO2012171332A1
(zh)
|
2011-06-16 |
2012-12-20 |
爱博新药研发(上海)有限公司 |
抑制丙型肝炎病毒的大环状杂环化合物及其制备和应用
|
US9636410B2
(en)
|
2011-07-06 |
2017-05-02 |
Glaxosmithkline Biologicals Sa |
Cationic oil-in-water emulsions
|
US9655845B2
(en)
|
2011-07-06 |
2017-05-23 |
Glaxosmithkline Biologicals, S.A. |
Oil-in-water emulsions that contain nucleic acids
|
EP2755981A4
(en)
|
2011-09-14 |
2015-03-25 |
Merck Sharp & Dohme |
HETEROCYCLIC COMPOUNDS CONTAINING SILYL AND METHODS OF USING THE SAME FOR TREATING VIRAL DISEASES
|
RU2014118727A
(ru)
|
2011-10-11 |
2015-11-20 |
Новартис Аг |
Рекомбинантные самореплицирующиеся полицистронные молекулы рнк
|
US20180044429A1
(en)
|
2015-03-09 |
2018-02-15 |
Celldex Therapeutics, Inc. |
Cd27 agonists
|
ES2832335T3
(es)
|
2015-03-27 |
2021-06-10 |
Ortho Clinical Diagnostics Inc |
Polipéptidos NS4A/NS3 modificado del VHC y usos de los mismos
|
EP3313863B1
(en)
|
2015-06-29 |
2020-12-23 |
The Board of Trustees of the Leland Stanford Junior University |
Degron fusion constructs and methods for controlling protein production
|
CN109071665B
(zh)
|
2016-04-18 |
2022-11-01 |
塞德斯医疗公司 |
结合人cd40的激动性抗体及其用途
|